tiprankstipranks
Trending News
More News >
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market

XORTX Therapeutics Inc (XRTX) Income Statement

Compare
76 Followers

XORTX Therapeutics Inc Income Statement

Last quarter (Q3 2025), XORTX Therapeutics Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, XORTX Therapeutics Inc's net income was $-642.27K. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -160.66K-$ -75.27K$ -17.88K$ -20.44K
Operating Expenses
$ 5.48M$ 4.81M$ 9.86M$ 2.90M$ 1.30M
Depreciation and Amortization
$ 160.66K$ 188.54K$ 75.27K$ 17.88K$ 20.44K
EBITDA
$ -4.38M-$ -9.41M-$ -1.25M
Operating Income
$ -5.64M-$ -12.43M-$ -1.08M
Other Income/Expenses
$ 1.10M$ 1.95M$ 2.95M$ 1.25M$ -202.36K
Pretax Income
$ -4.54M-$ -9.49M$ -1.65M$ -1.28M
Net Income
$ -4.54M--$ -1.65M$ -1.28M
Per Share Metrics
Basic EPS
$ -1.58$ -1.44$ -4.72$ -1.20$ -1.73
Diluted EPS
$ -1.58$ -1.44$ -4.72$ -1.20$ -1.73
Weighted Average Shares Outstanding
2.88M 1.98M 1.48M 1.09M 740.45K
Weighted Average Shares Outstanding (Diluted)
2.88M 1.98M 1.48M 1.09M 740.45K
Currency in USD

XORTX Therapeutics Inc Earnings and Revenue History